PRALUZATAMAB RAVTANSINE
UNII RD2I59M9FC

Substance Identification & Data

This profile provides standardized clinical and technical data for Praluzatamab Ravtansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RD2I59M9FC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2145115-85-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RD2I59M9FC

CAS Registry Number

2145115-85-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PRALUZATAMAB RAVTANSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C134697

National Cancer Institute reference terminology for clinical and research data.

INN ID

10939

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-169

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Praluzatamab Ravtansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.